About us
Fillmore Innovation Group was founded in response to the growing opioid health crisis in rural United States. Since then we have grown to other health sectors such as surgical tech and biotech.
Our biotech division is comprised of 3 full-time doctors and 4 biotech scientists, working together our Doctors provide on hands experience with the issues we are trying to tackle.
Surgery has become extremely important in treating most diseases and disorders, we strive to create tools to make these risky surgeries more precise and successful over the next 10 years.
Trust in us
Treating illness requires advances in medical treatment, this is one of Fillmore Innovation Group's main focuses.
We plan to battle addiction via therapeutic medical treatments which alter a users brain chemistry similar to nicotine treatments
Mental health plays a large role in an addicts drug habits, attacking the problem from both ends yields the best results
We are currently focused on four different projects at the moment. Two of which are leading the field in addiction treatment, specifically targeting opioids.
We still know very little about how an addiction affects the brain chemistry of a patient, by studying this we can find alternative treatments.
Mental health is a major attributing factor to the behavior of addicts, understanding more can lead to the developments of new techniques for treatment.
Our team is working hard to synthesize a new chemical that may alter the patients desire to seek out addictive substances.
We are striving to aid in the creation of new robotic surgery hardware to allow for remote surgical operations.